| Year |
Citation |
Score |
| 2023 |
Hensley C, Nyblade C, Zhou P, Parreño V, Ramesh A, Frazier A, Frazier M, Garrison S, Fantasia-Davis A, Cai R, Huang PW, Xia M, Tan M, Yuan L. Combined Live Oral Priming and Intramuscular Boosting Regimen with Rotarix and a Nanoparticle-Based Trivalent Rotavirus Vaccine Evaluated in Gnotobiotic Pig Models of G4P[6] and G1P[8] Human Rotavirus Infection. Vaccines. 11. PMID 37243031 DOI: 10.3390/vaccines11050927 |
0.462 |
|
| 2022 |
Nyblade C, Hensley C, Parreño V, Zhou P, Frazier M, Frazier A, Ramesh A, Lei S, Degiuseppe JI, Tan M, Yuan L. A New Gnotobiotic Pig Model of P[6] Human Rotavirus Infection and Disease for Preclinical Evaluation of Rotavirus Vaccines. Viruses. 14. PMID 36560807 DOI: 10.3390/v14122803 |
0.47 |
|
| 2014 |
Kocher J, Bui T, Giri-Rachman E, Wen K, Li G, Yang X, Liu F, Tan M, Xia M, Zhong W, Jiang X, Yuan L. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs. Journal of Virology. 88: 9728-43. PMID 24920797 DOI: 10.1128/Jvi.01249-14 |
0.453 |
|
| 2013 |
Bui T, Kocher J, Li Y, Wen K, Li G, Liu F, Yang X, LeRoith T, Tan M, Xia M, Zhong W, Jiang X, Yuan L. Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age. The Journal of General Virology. 94: 2005-16. PMID 23804568 DOI: 10.1099/Vir.0.054080-0 |
0.453 |
|
| Show low-probability matches. |